Literature DB >> 26991119

Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.

Birgit Burkhardt1, Stephanie Mueller1, Tasneem Khanam1, Sherrie L Perkins2.   

Abstract

The main challenges in the treatment of T-cell lymphoblastic lymphoma (T-LBL) in children and adolescents are twofold: to increase survival rates in concert with reduction of acute and long-term toxicities including the rate of secondary malignancies. The need for molecular and prognostic markers in T-LBL is crucial to allow for systematic treatment optimization and may serve as targets for new treatment approaches.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Paediatric T-lymphoblastic lymphoma; genetic classifier; molecular markers; risk group stratification; treatment

Mesh：

Year:  2016        PMID： 26991119     DOI： 10.1111/bjh.14017

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  9 in total

1.  Clinical and prognostic role of 2-[18F]FDG PET/CT and sarcopenia in treatment-naïve patients with T-cell lymphoblastic lymphoma.

Authors:  Xiaoyue Tan; Hui Yuan; Dongjiang Li; Xiaolin Sun; Chongyang Ding; Lei Jiang
Journal:  Ann Hematol       Date:  2022-09-19       Impact factor: 4.030

2.  Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.

Authors:  Michelle J Henderson; Klaartje Somers; Mawar Karsa; Angelika Kosciolek; Angelika Bongers; Anna Mariana; Tim Failes; Andrew J Gifford; Ursula R Kees; Laurence C Cheung; Rishi S Kotecha; Greg M Arndt; Michelle Haber; Murray D Norris; Rosemary Sutton; Richard B Lock
Journal:  Br J Cancer       Date:  2021-04-09       Impact factor: 7.640

3.  Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.

Authors:  David T Teachey; Meenakshi Devidas; Brent L Wood; Zhiguo Chen; Robert J Hayashi; Michelle L Hermiston; Robert D Annett; J Hunter Archer; Barbara L Asselin; Keith J August; Steve Y Cho; Kimberly P Dunsmore; Brian T Fisher; Jason L Freedman; Paul J Galardy; Paul Harker-Murray; Terzah M Horton; Alok I Jaju; Allison Lam; Yoav H Messinger; Rodney R Miles; Maki Okada; Samir I Patel; Eric S Schafer; Tal Schechter; Neelam Singh; Amii C Steele; Maria Luisa Sulis; Sarah L Vargas; Stuart S Winter; Charlotte Wood; Patrick Zweidler-McKay; Catherine M Bollard; Mignon L Loh; Stephen P Hunger; Elizabeth A Raetz
Journal:  J Clin Oncol       Date:  2022-03-10       Impact factor: 50.717

4.  Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.

Authors:  David M Habiel; Nicolas Krepostman; Michael Lilly; Karen Cavassani; Ana Lucia Coelho; Takehiko Shibata; Kojo Elenitoba-Johnson; Cory M Hogaboam
Journal:  Oncotarget       Date:  2016-12-13

5.  Outcome and Toxicity Patterns in Children and Adolescents with Non-Hodgkin Lymphoma: A Single Institution Experience.

Authors:  Paola Angelini; Laura Rodriguez; Mohammed Zolaly; Ahmed Naqvi; Sheila Weitzman; Oussama Abla; Angela Punnett
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-03-01       Impact factor: 2.576

6.  A case of conjunctival precursor T cell lymphoblastic lymphoma presenting with salmon colored conjunctival mass.

Authors:  Risa Sugawara; Yoshihiko Usui; Reisuke Takahashi; Toshitaka Nagao; Hiroshi Goto
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-31

7.  Systematic Oxidative Stress Indexes Associated with the Prognosis in Patients with T Lymphoblastic Lymphoma/Leukemia.

Authors:  Liqin Ping; Yan Gao; Yanxia He; Xiaoxiao Wang; Bing Bai; Cheng Huang; Huiqiang Huang
Journal:  Oxid Med Cell Longev       Date:  2022-08-04       Impact factor: 7.310

8.  T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report.

Authors:  Jiaoquan Chen; Xin Tian; Nanji Yu; Liqian Peng; Huilan Zhu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-23

9.  [Analysis of treatment response and prognostic factors of T-LBL patients treated with pediatric-like ALL therapy following HSCT].

Authors:  H T Wang; Y Dong; X T Gao; Z Wan; Y X Zhao; Y M Liu; L Liu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.